Prosecution Insights
Last updated: April 19, 2026

Generation Bio Co.

7 pending office actions

Portfolio Summary

7
Total Pending OAs
0
Final Rejections
7
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19063950 STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING VU, JAKE MINH 1618 Non-Final OA Feb 26, 2025
18289622 NON-VIRAL DNA VECTORS FOR VACCINE DELIVERY HILL, MYRON G 1671 Non-Final OA Nov 06, 2023
18015575 METHODS FOR ENCAPSULATING POLYNUCLEOTIDES INTO REDUCED SIZES OF LIPID NANOPARTICLES AND NOVEL FORMULATION THEREOF SONG, JIANFENG 1613 Non-Final OA Jan 11, 2023
17925404 NOVEL LIPIDS AND NANOPARTICLE COMPOSITIONS THEREOF POPA, ILEANA 1633 Non-Final OA Nov 15, 2022
17913477 NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING FACTOR IX THERAPEUTICS JOHNSON, ALLISON MARIE 1638 Non-Final OA Sep 22, 2022
17913482 NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING GAUCHER THERAPEUTICS KELLY, ROBERT M 1638 Non-Final OA Sep 22, 2022
17430341 MODULATION OF REP PROTEIN ACTIVITY IN CLOSED-ENDED DNA (CEDNA) PRODUCTION LIPPOLIS, ALEXANDRA ROSE 1637 Non-Final OA Aug 12, 2021

Managing Generation Bio Co.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month